Decreasing Risks of Surgical Site Infections and Optimizing Surgical Outcomes
Frank A. Buttacavoli, MD
Chief, Adult Reconstruction
AAOS, Hip & Knee Evaluation Committee
Associate Professor, Clinical
Department of Orthopedic Surgery
University of Texas Health, San Antonio
Saeed A. Chowdhry, MD, FACS
Plastic, Reconstructive & Aesthetic Surgery
Chicago Medical School, Chicago, IL
H. John Cooper, MD
Associate Professor of Orthopedic Surgery
Columbia University Irving Medical Center
NY Presbyterian Hospital, New York, NY
Ellen D. Dillavou, MD
Medical Director, Vascular Surgery
WakeMed Hospital System, Raleigh, NC
John P. Fischer, MD, MPH, FACS
Associate Professor of Surgery (Plastic Surgery)
Director of Clinical Research
University of Pennsylvania
Paul J. Kim, DPM, MS
Professor, Medical Director
University of Texas Southwestern, Dallas, TX
Seenu Reddy, MD
Chief. Division of Cardiothoracic Surgery
HCA TriStar Centennial Medical Center, Nashville, TN
Devinder Singh, MD
Chief, Professor & Program Director of Plastic Surgery
University of Miami & Jackson Health Systems Miami, FL
Provided by HMP Education, an HMP Global Company.
For questions regarding this educational activity, or to cancel your account, please call 609-371-1137 or email email@example.com.
This activity is designed for physician, physician assistants, nurses, nurse practitioners and podiatrists from plastic, ortho and general surgery departments.
After participating in this activity, learners should be better able to:
- Recognize the impact of surgical care complications as it relates to postoperative infections and identify patient populations at risk for surgical site compromise
- Examine the use of closed incision negative pressure wound therapy for patients at high risk for developing surgical site infection or who are undergoing a high-risk procedure
- Explain the process and implication of an FDA De Novo classification
- Review cases on the use of incision management on surgical incisions
- Employ best practice protocols in preventing surgical site infections
To be eligible for credit, participants must complete the educational activity and complete the evaluation form. Upon completing the activity, there will be instructions on how to complete the evaluation and print a certificate or other documentation of credit.
Release Date: August 24th, 2022
Expiration Date: February 24th, 2023
Estimated Time to Complete: 1.00 hour
There is no fee associated with this activity.
The evaluation is accessible after the activity via a PC or Mac computer with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications.
In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Note: This statement is not an indication of approved credits. Please see below for full accreditation details, including credit types and totals, for this activity.
HMP Education designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This continuing nursing education internet live activity awards 1.00 contact hour.
Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.00 contact hour.
American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.
HMP Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This internet live activity is designated for 1.00 AAPA Category 1 credit. PAs should only claim credit commensurate with the extent of their participation.
HMP Education is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. HMP Education has approved this internet live activity for a maximum of 1.00 continuing education contact hour.
USE OF PROPRIETARY NAMES
This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.
UNAPPROVED AND/OR INVESTIGATIONAL USES OF DRUGS AND DEVICES
This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of HMP Education.
The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.
Neither HMP Education nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.
The opinions expressed in this educational activity are those of the faculty and are not attributable to HMP Education or HMP. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
HMP Education is an independent provider of continuing medical education. HMP Education has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.
In accordance with our disclosure policies, HMP Education is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real conflicts of interest between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME.
Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:
- Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and;
- Any investigational, off-label, or non-FDA approved content or discussion
HMP Education has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.
Education has been independently peer-reviewed to validate content, mitigate identified conflicts of interest, and ensure:
- All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
- All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
- Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.
The faculty has reported the following:
Dr. Buttacavoli: Education Consultant— 3M KCI; Research Funding— 3M KCI
Dr. Chowdhry has disclosed no relevant financial relationship with any ineligible company (commercial interest).
Dr. Cooper: Consultant— 3M, Zimmer Biomet, DePuy
Dr. Dillavou: Consultant— WL Gore, 3M/KCI; Advisory Board— WL Gore, BD, Boston Scientific; Section Editor—UpToDate
Dr. Fischer: Consultant— BD, 3M, WL Gore, Integra, Baxter, AbbVie;
Dr. Kim: Consultant— 3M;
Dr. Reddy: Consultant— 3M
Dr. Singh has disclosed no relevant financial relationship with any ineligible company (commercial interest).
Daniel Federman, MD
Chief of Medicine
VA CT, 950 Campbell Ave
West Haven, CT
Dr. Federman has disclosed no relevant financial relationship with any ineligible company (commercial interest).
Susie Seaman, NP, MSN, CWCN, CWS (nurse planner)
Wound Clinic, Family Health Centers of San Diego
San Diego, California
Ms. Seaman has disclosed no relevant financial relationship with any ineligible company (commercial interest).
HMP Education planners and staff include Samantha Conforti, Randy Robbin, and Andrea Zimmerman.
No HMP Education planner or staff has disclosed a relevant financial relationship with any ineligible company (commercial interest).
HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.
HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint providers. HMP Education and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2022 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.
Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by HMP Education may contact Samantha Conforti, Senior Manager, Accreditation and Compliance, by phone at 609-371-1137, by email at firstname.lastname@example.org or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. Ms. Conforti will review the grievance and respond within 30 days of receiving the complaint.
Supported by an independent educational grant from 3M Health Care, Medical Solutions Division